{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:50:43Z","timestamp":1768974643837,"version":"3.49.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ncl.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:25:22Z","timestamp":1667089522000},"page":"177-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Headache in Adolescents"],"prefix":"10.1016","volume":"41","author":[{"given":"Irene","family":"Patniyot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Qubty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","article-title":"Migraine: Epidemiology, Burden, and Comorbidity","volume":"37","author":"Burch","year":"2019","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ncl.2008.11.003","article-title":"Pediatric Migraine","volume":"27","author":"Lewis","year":"2009","journal-title":"Neurol Clin"},{"issue":"10100","key":"10.1016\/j.ncl.2022.08.001_bib3","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2022.08.001_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-018-0846-2","article-title":"Migraine is first cause of disability in under 50s: will health politicians now take notice?","author":"Steiner","year":"2018","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.ncl.2022.08.001_bib5","first-page":"1","article-title":"Young people\u2019s health - A challenge for society","volume":"731","author":"Allain-Regnault","year":"1986","journal-title":"World Heal Organ - Tech Rep Ser"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1468-2982.2004.00757.x","article-title":"Development of a patient-based grading scale for PedMIDAS","volume":"24","author":"Hershey","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ncl.2022.08.001_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-1022-z","article-title":"New daily persistent headache: A systematic review on an enigmatic disorder","author":"Yamani","year":"2019","journal-title":"J\u00a0Headache Pain"},{"issue":"6","key":"10.1016\/j.ncl.2022.08.001_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/0333102418806869","article-title":"New daily persistent headache (NDPH) triggered by a single Valsalva event: A case series","volume":"39","author":"Rozen","year":"2019","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.ncl.2022.08.001_bib9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/0883073815624761","article-title":"New Daily Persistent Headache Is Most Likely to Begin at the Start of School","volume":"31","author":"Grengs","year":"2016","journal-title":"J Child Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/08830738211004514","article-title":"New Daily Persistent Headache in a Pediatric Population","volume":"36","author":"Strong","year":"2021","journal-title":"J\u00a0Child Neurol"},{"issue":"13","key":"10.1016\/j.ncl.2022.08.001_bib11","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/03331024211027560","article-title":"Pediatric-onset trigeminal autonomic cephalalgias: A systematic review and meta-analysis","volume":"41","author":"Ghosh","year":"2021","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.ncl.2022.08.001_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.0000000000008095","article-title":"Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"93","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ncl.2022.08.001_bib13","first-page":"789","article-title":"Short-term treatment of Migraine in Children and Adolescents","volume":"174","author":"Patniyot","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.48.1.103","article-title":"Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study","volume":"48","author":"H\u00e4m\u00e4l\u00e4inen","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/head.13663","article-title":"Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25\u00a0mg\/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study","volume":"60","author":"Lipton","year":"2020","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/head.12210","article-title":"Treatment of chronic migraine: A 3-month comparator study of naproxen sodium vs SumaRT\/Nap","volume":"54","author":"Cady","year":"2014","journal-title":"Headache"},{"issue":"9294","key":"10.1016\/j.ncl.2022.08.001_bib17","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT1B\/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib18","doi-asserted-by":"crossref","DOI":"10.1542\/peds.107.4.e62","article-title":"Tolerability and effectiveness of prochlorperazine for intractable migraine in children","volume":"107","author":"Kabbouche","year":"2001","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ncl.2022.08.001_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajem.2010.12.020","article-title":"Prochlorperazine in children with migraine: A look at its effectiveness and rate of akathisia","volume":"30","author":"Trottier","year":"2012","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0196-0644(03)00716-9","article-title":"Treatment of Pediatric Migraine Headaches: A Randomized, Double-Blind Trial of Prochlorperazine Versus Ketorolac","volume":"43","author":"Brousseau","year":"2004","journal-title":"Ann Emerg Med"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jemermed.2008.08.012","article-title":"Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department","volume":"39","author":"Trottier","year":"2010","journal-title":"J\u00a0Emerg Med"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/head.12255","article-title":"Chlorpromazine for the treatment of migraine in a pediatric emergency department","volume":"54","author":"Kanis","year":"2014","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/head.14091","article-title":"A\u00a0prospective, randomized, double-blind trial of intravenous chlorpromazine versus intravenous prochlorperazine for the treatment of acute migraine in adults presenting to the emergency department","volume":"61","author":"Hodgson","year":"2021","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","article-title":"The acute treatment of migraine in adults: The american headache society evidence assessment of migraine pharmacotherapies","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.ncl.2022.08.001_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0735-6757(96)90171-0","article-title":"Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache","volume":"14","author":"Jones","year":"1996","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.annemergmed.2007.09.027","article-title":"A\u00a0Randomized Controlled Trial of Prochlorperazine Versus Metoclopramide for Treatment of Acute Migraine","volume":"52","author":"Friedman","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"7","key":"10.1016\/j.ncl.2022.08.001_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain"},{"issue":"10200","key":"10.1016\/j.ncl.2022.08.001_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ncl.2022.08.001_bib29","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the Treatment of Migraine","volume":"381","author":"Dodick","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2022.08.001_bib30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5664\/jcsm.6288","article-title":"Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion","volume":"12","author":"Paruthi","year":"2016","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"S1","key":"10.1016\/j.ncl.2022.08.001_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/nure.12147","article-title":"Developmental changes in sleep biology and potential effects on adolescent behavior and caffeine use","volume":"72","author":"Carskadon","year":"2014","journal-title":"Nutr Rev"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2014-006748","article-title":"Sleep and use of electronic devices in adolescence: Results from a large population-based study","volume":"5","author":"Hysing","year":"2015","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ncl.2022.08.001_bib33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1152\/japplphysiol.00165.2011","article-title":"Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance","volume":"110","author":"Cajochen","year":"2011","journal-title":"J\u00a0Appl Physiol"},{"issue":"8","key":"10.1016\/j.ncl.2022.08.001_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00394-011-0263-7","article-title":"Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality","volume":"51","author":"Howatson","year":"2012","journal-title":"Eur J Nutr"},{"issue":"6","key":"10.1016\/j.ncl.2022.08.001_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0333102414547134","article-title":"Relationship of childhood headaches with preferences in leisure time activities, depression, anxiety and eating habits: A population-based, cross-sectional study","volume":"35","author":"Bekta\u015f","year":"2015","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.ncl.2022.08.001_bib36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0333102416649761","article-title":"Towards improved migraine management: Determining potential trigger factors in individual patients","volume":"37","author":"Peris","year":"2017","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.ncl.2022.08.001_bib37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/head.13535","article-title":"High School Start Time and Migraine Frequency in High School Students","volume":"59","author":"Gelfand","year":"2019","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of Migraine: A Disorder of Sensory Processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"issue":"11","key":"10.1016\/j.ncl.2022.08.001_bib39","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1468-2982.2009.01854.x","article-title":"The prevalence of premonitory symptoms in paediatric migraine: A questionnaire study in 103 children and adolescents","volume":"29","author":"Cuvellier","year":"2009","journal-title":"Cephalalgia"},{"issue":"4-Headache","key":"10.1016\/j.ncl.2022.08.001_bib40","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/CON.0000000000000624","article-title":"The Migraine Premonitory Phase","volume":"24","author":"Karsan","year":"2018","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2022.08.001_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11916-021-00966-z","article-title":"Dehydration and Headache","volume":"25","author":"Arca","year":"2021","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1113\/EP085449","article-title":"Mild dehydration modifies the cerebrovascular response to the cold pressor test","volume":"101","author":"Perry","year":"2016","journal-title":"Exp Physiol"},{"issue":"8","key":"10.1016\/j.ncl.2022.08.001_bib43","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2105\/AJPH.2015.302572","article-title":"Prevalence of inadequate hydration among US children and disparities by gender and race\/ethnicity: National Health and Nutrition Examination Survey, 2009-2012","volume":"105","author":"Kenney","year":"2015","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib44","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/fampra\/cmr112","article-title":"A\u00a0randomized trial on the effects of regular water intake in patients with recurrent headaches","volume":"29","author":"Spigt","year":"2012","journal-title":"Fam Pract"},{"key":"10.1016\/j.ncl.2022.08.001_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jocn.2020.05.034","article-title":"Association of drinking water and migraine headache severity","volume":"77","author":"Khorsha","year":"2020","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2022.08.001_bib46","doi-asserted-by":"crossref","unstructured":"Medicine I of. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate.; 2005. doi:10.17226\/10925.","DOI":"10.17226\/10925"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s10194-018-0902-y","article-title":"The association between migraine and physical exercise","volume":"19","author":"Amin","year":"2018","journal-title":"J\u00a0Headache Pain"},{"issue":"8","key":"10.1016\/j.ncl.2022.08.001_bib48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.0b013e3181eee244","article-title":"An unfavorable lifestyle and recurrent headaches among adolescents: The HUNT Study","volume":"75","author":"Robberstad","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000197218.05284.82","article-title":"Obesity and migraine: A population study","volume":"66","author":"Bigal","year":"2006","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.ncl.2022.08.001_bib50","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/0333102411419681","article-title":"Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls","volume":"31","author":"Varkey","year":"2011","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.ncl.2022.08.001_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1590\/0004-282X20140148","article-title":"Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: A randomized comparative study","volume":"72","author":"Santiago","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ncl.2022.08.001_bib52","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008105","article-title":"Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2022.08.001_bib53","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1610384","article-title":"Trial of amitriptyline, topiramate, and placebo for pediatric migraine","author":"Powers","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2022.08.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2020.09.009","article-title":"Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine","volume":"114","author":"Das","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib55","first-page":"385","article-title":"Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial","volume":"35","author":"Ebrahimi-Monfared","year":"2017","journal-title":"Restor Neurol Neurosci"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib56","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","article-title":"Research paper: Randomised clinical trial comparing melatonin 3\u00a0mg, amitriptyline 25\u00a0mg and placebo for migraine prevention","volume":"87","author":"Gon\u00e7alves","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039358","article-title":"Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis","volume":"11","author":"Sazali","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/head.13217","article-title":"Magnesium in Migraine Prophylaxis\u2014Is There an Evidence-Based Rationale? A Systematic Review","volume":"58","author":"von Luckner","year":"2018","journal-title":"Headache J Head Face Pain"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/head.13414","article-title":"Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents","volume":"58","author":"Szperka","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2022.08.001_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2020.09.014","article-title":"CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents","volume":"114","author":"Greene","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib61","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/head.14042","article-title":"Remote electrical neuromodulation for acute treatment of migraine in adolescents","volume":"61","author":"Hershey","year":"2021","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0333102418811573","article-title":"Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial","volume":"39","author":"Chou","year":"2019","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2022.08.001_bib63","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1007\/s10072-017-2942-5","article-title":"No Title","volume":"38","author":"Grazzi","year":"2017","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.ncl.2022.08.001_bib64","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/head.13284","article-title":"Transcranial Magnetic Stimulation for Migraine Prevention in Adolescents: A Pilot Open-Label Study","volume":"58","author":"Irwin","year":"2018","journal-title":"Headache"},{"issue":"13","key":"10.1016\/j.ncl.2022.08.001_bib65","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1212\/WNL.0000000000003760","article-title":"Nonpainful remote electrical stimulation alleviates episodic migraine pain","volume":"88","author":"Yarnitsky","year":"2017","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2022.08.001_bib66","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib67","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/head.12605","article-title":"Cognitive-behavioral therapy: How medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine","volume":"55","author":"Ernst","year":"2015","journal-title":"Headache"},{"issue":"24","key":"10.1016\/j.ncl.2022.08.001_bib68","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1001\/jama.2013.282533","article-title":"Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: A randomized clinical trial","volume":"310","author":"Power","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ncl.2022.08.001_bib69","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/head.12795","article-title":"Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to \u22644 per Month","volume":"56","author":"Kroner","year":"2016","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.ncl.2022.08.001_bib70","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/head.13772","article-title":"Biofeedback Treatment App for Pediatric Migraine: Development and Usability Study","volume":"60","author":"Stubberud","year":"2020","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib71","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/head.14010","article-title":"Smartphone-Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial","volume":"60","author":"Minen","year":"2020","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.ncl.2022.08.001_bib72","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/head.12939","article-title":"Patterns of Use of Peripheral Nerve Blocks and Trigger Point Injections for Pediatric Headache: Results of a Survey of the American Headache Society Pediatric and Adolescent Section","volume":"56","author":"Szperka","year":"2016","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pediatrneurol.2013.09.008","article-title":"Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders","volume":"50","author":"Gelfand","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2022.08.001_bib74","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/head.12729","article-title":"The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache","volume":"56","author":"Robbins","year":"2016","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/head.12458","article-title":"A\u00a0double-blind, placebo-controlled study of repetitive transnasal sphenopalatine ganglion blockade with Tx360\u00ae as acute treatment for chronic migraine","volume":"55","author":"Cady","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.ncl.2022.08.001_bib76","article-title":"Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache","volume":"2018","author":"Binfalah","year":"2018","journal-title":"Pain Res Treat"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib77","first-page":"E111","article-title":"Sphenopalatine ganglion nerve block for the treatment of migraine headaches in the pediatric population","volume":"24","author":"Mousa","year":"2021","journal-title":"Pain Physician"},{"issue":"7","key":"10.1016\/j.ncl.2022.08.001_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/children8070606","article-title":"Transnasal sphenopalatine ganglion block for the preventive treatment of chronic daily headache in adolescents","volume":"8","author":"Kouri","year":"2021","journal-title":"Children"},{"issue":"12","key":"10.1016\/j.ncl.2022.08.001_bib79","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/0883073820931256","article-title":"The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review","volume":"35","author":"Marcelo","year":"2020","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.ncl.2022.08.001_bib80","article-title":"Is Botox right for me: When to assess the efficacy of the Botox injection for chronic migraine in pediatric population","author":"Goenka","year":"2022","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.ncl.2022.08.001_bib81","article-title":"Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients","volume":"11","author":"Ali","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ncl.2022.08.001_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/rapm-2020-101605","article-title":"Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population","volume":"46","author":"Shah","year":"2021","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ncl.2022.08.001_bib83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2022.02.002","article-title":"Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine","volume":"130","author":"Goenka","year":"2022","journal-title":"Pediatr Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861922000615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861922000615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:21:33Z","timestamp":1760005293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861922000615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0733861922000615"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2022.08.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Headache in Adolescents","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}